Yahoo Web Search

Sign In

Search results

  1. mivision.com.au › 2023 › 06Tepezza Effective For Treating Thyroid Eye Disease: Study

    Jul 15, 2024 · The results of a real-world treatment for patients with thyroid eye disease (TED) who also have dysthyroid optic neuropathy (DON) indicated that Tepezza (teprotumumab-trbw) was effective for managing DON, according to recent study results.

  2. tracxn.com › d › companiesHorizon Therapeutics - Company Profile - Tracxn

    Jul 11, 2024 · Horizon Therapeutics - Developer of drugs for treating rare and autoimmune diseases. Acquired by Amgen. Raised a total funding of $61.8M over 7 rounds from 6 investors. Horizon Therapeutics has 622 competitors.

  3. Videos

    View all

  4. pharmaphorum.com › news › reports-say-ftc-planning-block-amgenReports say FTC is planning to block Amgen’s Horizon deal

    Jul 17, 2024 · Shares in Horizon Therapeutics have been in sharp decline after reports emerged that the US financial regulator is preparing a challenge to its $28 billion takeover by Amgen.

  5. www.globenewswire.com › news-release › 2024/07/04Thyroid Eye Disease Market to Accelerate Substantially by -...

    Jul 4, 2024 · Until today, only one drug, developed by Horizon Therapeutics (now acquired by Amgen), has been approved by the FDA in 2020 for treating adults with thyroid eye disease.

  6. www.marketbeat.com › stocks › NASDAQHorizon Therapeutics Public (HZNP) Stock Price, News & Analysis

    1 day ago · Should You Buy or Sell Horizon Therapeutics Public Stock? Get The Latest HZNP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

    • 1 BURLINGTON ROAD CONNAUGHT HOUSE 1ST FLOOR, Dublin L2, D04 C5Y6
    • investor-relations@horizontherapeutics.com
    • (531) 772-2100
    • 2.1K

  7. www.jaad.org › article › S0190-9622(24)02550-7Efficacy and safety of deuruxolitinib, an oral selective Janus...

    3 days ago · Dr King has served on advisory boards and/or is a consultant and/or is a clinical trial investigator for AbbVie, AltruBio Inc., Almirall, AnaptysBio, Arena Pharmaceuticals, Bioniz Therapeutics, Bristol-Myers Squibb, CoNCERT Pharmaceuticals (subsequently acquired by Sun Pharmaceutical Industries Limited), Equillium, Horizon Therapeutics, Eli ...

  8. www.biomarin.comBioMarin Pharmaceutical Inc.

    Jun 28, 2024 · BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. Learn more.